Recombinant Factor VIII Products and Inhibitor Development in Previously Untreated Patients with Severe Haemophilia A: Combined Analysis of Three Studies
Peter Volkers
(1)
,
Kay-Martin Hanschmann
(1)
,
Thierry Calvez
(2)
,
Hervé Chambost
(3)
,
Peter W. Collins
(4)
,
Virginie Demiguel
(5)
,
Daniel P. Hart
(6, 7)
,
Charles R.M. Hay
(8)
,
Jenny Goudemand
(9)
,
Rolf Ljung
(10)
,
Ben P. Palmer
,
Elena Santagostino
(11)
,
Ella M. Van Hardeveld
(12)
,
Marijke van Den Berg
(12)
,
Brigitte Keller-Stanislawski
(1)
1
EPI -
Paul-Ehrlich-Institute - Federal Institute for Vaccines and Biomedicines
2 iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique
3 TIMONE - Hôpital de la Timone [CHU - APHM]
4 Cardiff University
5 Santé publique France - French National Public Health Agency [Saint-Maurice, France]
6 Barts & The London School of Medicine and Dentistry
7 QMUL - Queen Mary University of London
8 Manchester Royal Infirmary
9 CHRU Lille - Centre Hospitalier Régional Universitaire [CHU Lille]
10 Skane University Hospital [Lund]
11 Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
12 PedNet Haemophilia Research Foundation
2 iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique
3 TIMONE - Hôpital de la Timone [CHU - APHM]
4 Cardiff University
5 Santé publique France - French National Public Health Agency [Saint-Maurice, France]
6 Barts & The London School of Medicine and Dentistry
7 QMUL - Queen Mary University of London
8 Manchester Royal Infirmary
9 CHRU Lille - Centre Hospitalier Régional Universitaire [CHU Lille]
10 Skane University Hospital [Lund]
11 Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
12 PedNet Haemophilia Research Foundation
Thierry Calvez
- Function : Author
- PersonId : 1360662
- IdRef : 032105428
Ben P. Palmer
- Function : Author